Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05999123 · ClinicalTrials.gov registry record
Menstrual Cycle Study
A clinical trial of Menstruation and Ovulation, sponsored by Fitbit.
- Completed
- Registry status
- 143
- Enrollment target
- 1
- Study location
NCT05999123 is a study of Menstruation and Ovulation that has completed, run by Fitbit. The registered enrollment target is 143 participants, below the 166,711-participant average among 3 other Menstruation trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05999123, a study of Menstruation and Ovulation, has completed, sponsored by Fitbit.
- COMPLETED
- Registry status
- 143 participants
- Enrollment target
- 1
- Study location
Study Summary
A data collection study to develop algorithms to estimate menstrual cycle phases.
Conditions Studied
Study Locations (1)
California
- Artemis Headlands LLC (Artemis Institute for Clinical Research) - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 143 participants |
| Start Date | 2023-07-25 |
| Est. Completion | 2024-08-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05999123
The ClinicalTrials.gov registry entry for NCT05999123 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 143 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 166,711-participant average among 3 other Menstruation trials with a reported enrollment target (100% lower). The listed sponsor is Fitbit, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Menstruation appearing as the primary indexed condition, and to 0 interventions.
NCT05999123 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05999123 about?
NCT05999123 is a clinical study titled "Menstrual Cycle Study". A data collection study to develop algorithms to estimate menstrual cycle phases.
What is the current status of trial NCT05999123?
This trial is currently completed. The enrollment target is 143 participants. The study started on 2023-07-25. Estimated completion is 2024-08-30.
What conditions does trial NCT05999123 study?
This clinical trial studies the following conditions: Menstruation, Ovulation.
Who is sponsoring clinical trial NCT05999123?
This trial is sponsored by Fitbit, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05999123 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Menstruation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.